Filing Analysis
Regulation FD Disclosure
Filed Mar 09, 2026
LOW
Coherus Oncology, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The results were disclosed via a press release furnished as Exhibit 99.1 to the filing.
Key Facts
- The filing reports financial results for the period ended December 31, 2025.
- The report was filed on March 9, 2026, under Item 2.02 (Results of Operations and Financial Condition).
- The information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- The report was signed by CEO Dennis M. Lanfear.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.